<?xml version="1.0" encoding="UTF-8"?>
<p>So far, only trivalent inactivated influenza vaccine (TIV) have been available in the market in China. It was shown that the influenza B strain included in TIV did not match the dominant circulating lineage at least in five of the nine vaccination years studied (
 <xref ref-type="fig" rid="fig03">Fig. 3</xref>). 
</p>
